Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

OBJECTIVE The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. CONCLUSIONS Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.

[1]  C. Mathieu,et al.  2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2019, Diabetologia.

[2]  David M Maahs,et al.  State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. , 2019, Diabetes technology & therapeutics.

[3]  Deepak L. Bhatt,et al.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.

[4]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[5]  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[6]  12. Older Adults: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[7]  5. Lifestyle Management: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[8]  11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[9]  R. Collins,et al.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.

[10]  Geltrude Mingrone,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2018, Diabetes Care.

[11]  M. Blaha,et al.  Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention Guidelines , 2018, Current Treatment Options in Cardiovascular Medicine.

[12]  Björn Eliasson,et al.  Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes , 2018, The New England journal of medicine.

[13]  Alyson K. Myers,et al.  Obesity, obstructive sleep apnea and type 2 diabetes mellitus: Epidemiology and pathophysiologic insights , 2018, Sleep medicine and disorders : international journal.

[14]  M. Conaway,et al.  Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy , 2018, Neurology.

[15]  Wilbert S Aronow,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.

[16]  J. Williamson,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.

[17]  Amber D. Seelig,et al.  Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study , 2018, Diabetes Care.

[18]  D. Reda,et al.  Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT) , 2018, Diabetologia.

[19]  Karla I. Galaviz,et al.  Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials , 2017, JAMA internal medicine.

[20]  M. Bernstein Nutritional Needs of the Older Adult. , 2017, Physical medicine and rehabilitation clinics of North America.

[21]  N. H. Ismail,et al.  Assessing the nutritional status of hospitalized elderly , 2017, Clinical interventions in aging.

[22]  Dave L Dixon,et al.  Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP , 2017, Diabetes Care.

[23]  J. Logomarsino,et al.  Evaluating the effectiveness of five screening tools used to identify malnutrition risk in hospitalized elderly: A systematic review , 2017, Geriatric nursing.

[24]  A. Sinclair,et al.  Frailty and sarcopenia - newly emerging and high impact complications of diabetes. , 2017, Journal of diabetes and its complications.

[25]  I. D. de Boer,et al.  Diabetes and Hypertension: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.

[26]  K. Fujisue,et al.  Current status of lipid management in acute coronary syndrome. , 2017, Journal of cardiology.

[27]  D. Armstrong,et al.  Diabetic Foot Ulcers and Their Recurrence. , 2017, The New England journal of medicine.

[28]  D. Armstrong,et al.  Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S. , 2017, Diabetes Care.

[29]  K. Mahaffey,et al.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.

[30]  B. Zinman,et al.  Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes , 2017, The New England journal of medicine.

[31]  A. Chaudhary,et al.  Acute Pancreatitis Secondary to Severe Hypertriglyceridemia: Management of Severe Hypertriglyceridemia in Emergency Setting , 2017, Gastroenterology research.

[32]  Ju Han Kim,et al.  Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients. , 2017, International journal of cardiology.

[33]  D. Mark,et al.  Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial) , 2017, Circulation. Cardiovascular quality and outcomes.

[34]  K. Ruedy,et al.  Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial , 2017, Journal of diabetes science and technology.

[35]  Eliot A Brinton,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[36]  Nadeem Shafique Butt,et al.  Effect of diet on type 2 diabetes mellitus: A review , 2017, International journal of health sciences.

[37]  T. Wilt,et al.  Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians , 2017, Annals of Internal Medicine.

[38]  J. Halter,et al.  The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations , 2017, Diabetes Care.

[39]  G. Umpierrez,et al.  Management of Inpatient Hyperglycemia and Diabetes in Older Adults , 2017, Diabetes Care.

[40]  D. Giugliano,et al.  Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials , 2017, Diabetes Care.

[41]  M. Barry,et al.  Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. , 2017, Annals of internal medicine.

[42]  Jennifer K. Sun,et al.  Diabetic Retinopathy: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.

[43]  Yu Gu,et al.  Are falls prevention programs effective at reducing the risk factors for falls in people with type-2 diabetes mellitus and peripheral neuropathy: A systematic review with narrative synthesis. , 2017, Journal of diabetes and its complications.

[44]  L. Kappelle,et al.  Chronic hyperglycemia is related to poor functional outcome after acute ischemic stroke , 2017, International journal of stroke : official journal of the International Stroke Society.

[45]  Jing-Shiang Hwang,et al.  Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study. , 2017, International journal of cardiology.

[46]  D. Kansagara,et al.  Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older , 2017, Annals of Internal Medicine.

[47]  M. Signy,et al.  Ezetimibe: an update on its clinical usefulness in specific patient groups , 2017, Therapeutic advances in chronic disease.

[48]  Jonathan E. Brown,et al.  Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. , 2016, Diabetes & metabolism.

[49]  D. Dunstan,et al.  Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association , 2016, Diabetes Care.

[50]  J. Potter,et al.  Which Frail Older People Are Dehydrated? The UK DRIE Study. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[51]  E. Koo,et al.  The Utility of Brief Cognitive Tests for Patients With Type 2 Diabetes Mellitus: A Systematic Review. , 2016, Journal of the American Medical Directors Association.

[52]  C. O'connor,et al.  A Comprehensive Review of the Literature Supporting Recommendations From the Canadian Diabetes Association for the Use of a Plant-Based Diet for Management of Type 2 Diabetes. , 2016, Canadian journal of diabetes.

[53]  B. Draznin,et al.  IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[54]  A. Ades,et al.  Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes-Network meta-analysis of randomized trials. , 2016, Journal of diabetes and its complications.

[55]  Svetlana K. Eden,et al.  The diabetes nutrition education study randomized controlled trial: A comparative effectiveness study of approaches to nutrition in diabetes self-management education. , 2016, Patient education and counseling.

[56]  F. Schmitt,et al.  Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.

[57]  A. Solini,et al.  What Should Be the Target Blood Pressure in Elderly Patients With Diabetes? , 2016, Diabetes Care.

[58]  R. DeFronzo,et al.  Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment Algorithm , 2016, Diabetes Care.

[59]  John M Lachin,et al.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. , 2016, The New England journal of medicine.

[60]  J. Buse,et al.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[61]  D. Goff,et al.  Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study , 2016, Diabetes Care.

[62]  G. Bakris,et al.  Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What’s the Fuss? , 2016, Diabetes Care.

[63]  J. Rosenstock,et al.  Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial , 2016, Diabetes Care.

[64]  Ryan T. Crews,et al.  Role and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation , 2016, Diabetes Care.

[65]  Naveed Sattar,et al.  The changing face of diabetes complications. , 2016, The lancet. Diabetes & endocrinology.

[66]  L. Kappelle,et al.  Case‐finding for cognitive impairment among people with Type 2 diabetes in primary care using the Test Your Memory and Self‐Administered Gerocognitive Examination questionnaires: the Cog‐ID study , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[67]  R. Gilbert,et al.  Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies. , 2016, Canadian journal of diabetes.

[68]  J. Manson,et al.  Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women , 2016, European Journal of Epidemiology.

[69]  G. Mancia,et al.  Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials , 2016, Hypertension.

[70]  V. Perkovic,et al.  Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. , 2016, The lancet. Diabetes & endocrinology.

[71]  C. Shin,et al.  Risk of fractures and diabetes medications: a nationwide cohort study , 2016, Osteoporosis International.

[72]  A. Vinik CLINICAL PRACTICE. Diabetic Sensory and Motor Neuropathy. , 2016, The New England journal of medicine.

[73]  Laura G. Qualls,et al.  TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[74]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[75]  J. Manson,et al.  Multiple Healthful Dietary Patterns and Type 2 Diabetes in the Women's Health Initiative. , 2016, American journal of epidemiology.

[76]  R. Varma,et al.  Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010). , 2016, Ophthalmic surgery, lasers & imaging retina.

[77]  B. Timar,et al.  Age as an independent factor for the development of neuropathy in diabetic patients , 2016, Clinical interventions in aging.

[78]  Sei J. Lee,et al.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. , 2016, JAMA.

[79]  A. Sinclair,et al.  Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis , 2016, Journal of the American Geriatrics Society.

[80]  B. Davis,et al.  Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses , 2016, PLoS medicine.

[81]  P. Katzmarzyk,et al.  Blood pressure and all-cause mortality among patients with type 2 diabetes. , 2016, International journal of cardiology.

[82]  B. Carlberg,et al.  Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses , 2016, British Medical Journal.

[83]  G. Bray,et al.  Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. , 2016, The Journal of clinical endocrinology and metabolism.

[84]  C. Mathieu,et al.  Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort Study. , 2016, The Journal of clinical endocrinology and metabolism.

[85]  U. Iloeje,et al.  ASSOCIATION BETWEEN HYPOGLYCEMIA AND FALL-RELATED FRACTURES AND HEALTH CARE UTILIZATION IN OLDER VETERANS WITH TYPE 2 DIABETES. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[86]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[87]  W. Cushman,et al.  Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes , 2016, Diabetes Care.

[88]  K. Khunti,et al.  Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments , 2016, Annals of Internal Medicine.

[89]  Tracey H. Taveira,et al.  Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association , 2016, Diabetes Care.

[90]  Irl B Hirsch,et al.  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[91]  M. Foster,et al.  Type 2 diabetes–related foot care knowledge and foot self-care practice interventions in the United States: a systematic review of the literature , 2016, Diabetic foot & ankle.

[92]  S. Bus,et al.  Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review , 2016, Diabetes/metabolism research and reviews.

[93]  R. Beck,et al.  Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes , 2015, Diabetes Care.

[94]  P. Guarino,et al.  BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[95]  S. Solomon,et al.  Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. , 2015, The New England journal of medicine.

[96]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[97]  J. Morley,et al.  Rapid screening for sarcopenia , 2015, Journal of cachexia, sarcopenia and muscle.

[98]  N. Freemantle,et al.  IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy , 2015, Diabetes Therapy.

[99]  L. Chuang,et al.  Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[100]  Jennifer G. Robinson,et al.  Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.

[101]  P. Remington,et al.  Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force , 2015, Annals of Internal Medicine.

[102]  E. Barrett-Connor,et al.  Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study , 2015, The lancet. Diabetes & endocrinology.

[103]  Deepak L. Bhatt,et al.  Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry , 2015, Circulation.

[104]  L. Geiss,et al.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.

[105]  A. García-de-Lorenzo,et al.  PREDyCES study: The cost of hospital malnutrition in Spain. , 2015, Nutrition.

[106]  D. Klonoff,et al.  PRIDE Statement on the Need for a Moratorium on the CMS Plan to Cite Hospitals for Performing Point-of-Care Capillary Blood Glucose Monitoring on Critically Ill Patients. , 2015, The Journal of clinical endocrinology and metabolism.

[107]  G. Umpierrez,et al.  A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities , 2015, BMJ Open Diabetes Research and Care.

[108]  D. Margolis,et al.  Diabetes, Lower-Extremity Amputation, and Death , 2015, Diabetes Care.

[109]  G. Meininger,et al.  Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program , 2015, Diabetes Care.

[110]  M. Pencina,et al.  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. , 2015, The New England journal of medicine.

[111]  G. Umpierrez,et al.  BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[112]  C. Mazzucchelli,et al.  Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–149 , 2015, Diabetes Care.

[113]  I. Hirsch,et al.  Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition , 2015, Diabetes Care.

[114]  Mark E. Molitch,et al.  Management of diabetes mellitus in patients with chronic kidney disease , 2015, Clinical Diabetes and Endocrinology.

[115]  D. Reda,et al.  Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. , 2015, The New England journal of medicine.

[116]  Nataliya Shinkazh,et al.  Pharmacological treatment of diabetic peripheral neuropathy. , 2015, P & T : a peer-reviewed journal for formulary management.

[117]  H. Krum,et al.  Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy , 2015, The Lancet.

[118]  Kamlesh Khunti,et al.  Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) , 2015, Diabetes Care.

[119]  David M Maahs,et al.  Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry , 2015, Diabetes Care.

[120]  G. Guyatt,et al.  Guideline panels should not GRADE good practice statements. , 2015, Journal of clinical epidemiology.

[121]  Deepak L. Bhatt,et al.  Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials. , 2015, The lancet. Diabetes & endocrinology.

[122]  G. Bakris,et al.  Update on Blood Pressure Goals in Diabetes Mellitus , 2015, Current Cardiology Reports.

[123]  Jennifer G. Robinson,et al.  Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.

[124]  A. Sinclair,et al.  Diabetes in older people: new insights and remaining challenges. , 2015, The lancet. Diabetes & endocrinology.

[125]  Jennifer K. Sun,et al.  Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. , 2015, The New England journal of medicine.

[126]  M. Maguire,et al.  Treatment choice for diabetic macular edema. , 2015, The New England journal of medicine.

[127]  Steven J. Brown,et al.  Diabetic Peripheral Neuropathy Compromises Balance During Daily Activities , 2015, Diabetes Care.

[128]  Sei J. Lee,et al.  Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. , 2015, JAMA internal medicine.

[129]  F. Sloan,et al.  Causes of the Change in the Rates of Mortality and Severe Complications of Diabetes Mellitus: 1992–2012 , 2015, Medical care.

[130]  C. Lyketsos,et al.  Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. , 2015, The American journal of psychiatry.

[131]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[132]  Lee Hooper,et al.  Increasing fluid intake and reducing dehydration risk in older people living in long-term care: a systematic review. , 2015, Journal of the American Medical Directors Association.

[133]  H. Keller,et al.  Improving food and fluid intake for older adults living in long-term care: a research agenda. , 2015, Journal of the American Medical Directors Association.

[134]  B. Hawkins,et al.  Blood pressure control for diabetic retinopathy. , 2015, The Cochrane database of systematic reviews.

[135]  H. Sørensen,et al.  Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study , 2015, Diabetes Care.

[136]  R. MacIsaac,et al.  Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: an analysis of intervention trials , 2015, Journal of Human Hypertension.

[137]  B. Zinman,et al.  Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. , 2015, JAMA.

[138]  Silvio E. Inzucchi,et al.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review. , 2014, JAMA.

[139]  R. Gómez-Huelgas,et al.  Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine , 2014, BMC Cardiovascular Disorders.

[140]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[141]  Walter T Ambrosius,et al.  The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. , 2014, Ophthalmology.

[142]  Michael E. Miller,et al.  Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial , 2014, The Lancet.

[143]  N. Bressler,et al.  Prevalence of and risk factors for diabetic macular edema in the United States. , 2014, JAMA ophthalmology.

[144]  Yun-fa Jiang,et al.  Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. , 2014, Bone.

[145]  M. Malone,et al.  The effect of diabetes mellitus on costs and length of stay in patients with peripheral arterial disease undergoing vascular surgery. , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[146]  G. Biolo,et al.  Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. , 2014, Clinical nutrition.

[147]  I. D. de Boer,et al.  Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.

[148]  A. Sinclair,et al.  Diabetes and dementia in older people: a Best Clinical Practice Statement by a multidisciplinary National Expert Working Group , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[149]  G. Umpierrez,et al.  Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes , 2014, Diabetes Care.

[150]  M. Martinez-Alonso,et al.  A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications , 2014, Health and Quality of Life Outcomes.

[151]  D. Blazer,et al.  Substance abuse among older adults. , 2014, Clinics in geriatric medicine.

[152]  X. Wan,et al.  Meta-analysis of the risk of cataract in type 2 diabetes , 2014, BMC Ophthalmology.

[153]  G. Bakris,et al.  Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy , 2014, American Journal of Nephrology.

[154]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.

[155]  Kevin P. High,et al.  Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions , 2014, Diabetes.

[156]  E. Rivero-Ferrer,et al.  Incidence of Retinal Complications in a Cohort of Newly Diagnosed Diabetic Patients , 2014, PloS one.

[157]  D. Sacks,et al.  Interpretation of hemoglobin A1c values. , 2014, JAMA.

[158]  M. Molitch,et al.  Insulin therapy for type 2 diabetes mellitus. , 2014, JAMA.

[159]  F. Hu,et al.  Prevention and management of type 2 diabetes: dietary components and nutritional strategies , 2014, The Lancet.

[160]  Virginia A. Moyer Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. , 2014, Annals of internal medicine.

[161]  R. Kruse,et al.  Impact of amputation level and comorbidities on functional status of nursing home residents after lower extremity amputation. , 2014, Journal of vascular surgery.

[162]  T. Mueller,et al.  Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. , 2014, Journal of vascular surgery.

[163]  Xuelin He,et al.  Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. , 2014, JAMA internal medicine.

[164]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[165]  G. Guyatt,et al.  Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies , 2014, BMJ : British Medical Journal.

[166]  Jose M Garcia,et al.  Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review , 2014, Gerontology.

[167]  J. Núñez,et al.  Prognostic value of admission glycated haemoglobin in unknown diabetic patients with acute myocardial infarction , 2014, European heart journal. Acute cardiovascular care.

[168]  L. Hooper,et al.  Water-loss dehydration and aging , 2014, Mechanisms of Ageing and Development.

[169]  Howard G. Birnbaum,et al.  Burden of Diabetic Foot Ulcers for Medicare and Private Insurers , 2014, Diabetes Care.

[170]  G. Bakris,et al.  Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga , 2014, Diabetes Care.

[171]  Arlene Smaldone,et al.  Diabetes Self-Care and the Older Adult , 2014, Western journal of nursing research.

[172]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[173]  S. Colagiuri,et al.  Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. , 2014, The lancet. Diabetes & endocrinology.

[174]  Jennifer Y. Liu,et al.  Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. , 2014, JAMA internal medicine.

[175]  A. Schwartz,et al.  Eight-Year Weight Losses with an Intensive Lifestyle Intervention: The Look AHEAD Study , 2014, Obesity.

[176]  L. Aiello Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.

[177]  J. Meyers,et al.  Burden of Sliding Scale Insulin Use in Elderly Long‐Term Care Residents with Type 2 Diabetes Mellitus , 2013, Journal of the American Geriatrics Society.

[178]  A. Keech,et al.  An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes , 2013, Diabetes.

[179]  P. Peduzzi,et al.  Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.

[180]  Elizabeth Eckstrom,et al.  Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.

[181]  G. Umpierrez,et al.  Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study. , 2013, Journal of the American Medical Directors Association.

[182]  José Agustín Arguedas,et al.  Blood pressure targets for hypertension in people with diabetes mellitus. , 2013, The Cochrane database of systematic reviews.

[183]  Wei-Chih Liao,et al.  Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis , 2013, BMJ.

[184]  S. Heymsfield,et al.  HbA1c and Lower-Extremity Amputation Risk in Low-Income Patients With Diabetes , 2013, Diabetes Care.

[185]  Craig Wilson,et al.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes. , 2013, The New England journal of medicine.

[186]  Deepak L. Bhatt,et al.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.

[187]  J M Sparrow,et al.  United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services , 2013, Eye.

[188]  H. Comber,et al.  Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) , 2013, PloS one.

[189]  A. Philis-Tsimikas Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control. , 2013, The American journal of medicine.

[190]  J. Stein,et al.  Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. , 2013, Ophthalmology.

[191]  B. Frier,et al.  Diabetes and driving , 2013, Diabetes, obesity & metabolism.

[192]  C. Attinger,et al.  Inpatient Management of Diabetic Foot Disorders: A Clinical Guide , 2013, Diabetes Care.

[193]  E. Simonsick,et al.  Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. , 2013, JAMA internal medicine.

[194]  David R. Sinacore,et al.  Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial , 2013, International Journal of Obesity.

[195]  R. Beck,et al.  Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. , 2013, The Journal of clinical endocrinology and metabolism.

[196]  S. Heymsfield,et al.  Aggressive Blood Pressure Control Increases Coronary Heart Disease Risk Among Diabetic Patients , 2013, Diabetes Care.

[197]  P. Kearney,et al.  Does contact with a podiatrist prevent the occurrence of a lower extremity amputation in people with diabetes? A systematic review and meta-analysis , 2013, BMJ Open.

[198]  Paul P. Lee,et al.  TEN-YEAR INCIDENCE OF AGE-RELATED MACULAR DEGENERATION ACCORDING TO DIABETIC RETINOPATHY CLASSIFICATION AMONG MEDICARE BENEFICIARIES , 2013, Retina.

[199]  A. Bhansali,et al.  Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies , 2013, Journal of diabetes investigation.

[200]  A. Turchin,et al.  Hypoglycemia, With or Without Insulin Therapy, Is Associated With Increased Mortality Among Hospitalized Patients , 2013, Diabetes Care.

[201]  M. Marre,et al.  Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency , 2013, Diabetes Care.

[202]  G. Umpierrez,et al.  Contributions of Basal and Prandial Hyperglycemia to Total Hyperglycemia in Older and Younger Adults with Type 2 Diabetes Mellitus , 2013, Journal of The American Geriatrics Society.

[203]  B. Draznin,et al.  Practical Approach to Management of Inpatient Hyperglycemia in Select Patient Populations , 2013, Hospital practice.

[204]  Daniala L. Weir,et al.  Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure: Systematic Review of Observational Studies Involving 34 000 Patients , 2013, Circulation. Heart failure.

[205]  C. Cook,et al.  Trends in glycemic control over a 2-year period in 126 US hospitals. , 2013, Journal of hospital medicine.

[206]  M. Stellefson,et al.  The Chronic Care Model and Diabetes Management in US Primary Care Settings: A Systematic Review , 2013, Preventing chronic disease.

[207]  Limin Peng,et al.  Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes , 2013, Diabetes Care.

[208]  Sai V. Yalla,et al.  A Growing Troubling Triad: Diabetes, Aging, and Falls , 2013, Journal of aging research.

[209]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[210]  Nathaniel Clark,et al.  Diabetes in Older Adults: A Consensus Report , 2012, Journal of the American Geriatrics Society.

[211]  M. Kabeto,et al.  Clinical complexity and mortality in middle-aged and older adults with diabetes. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[212]  B. Frier,et al.  Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs , 2012, Diabetes, obesity & metabolism.

[213]  Nathaniel Clark,et al.  Diabetes in Older Adults , 2012, Diabetes Care.

[214]  Thomas J. Songer,et al.  Improvements in the Life Expectancy of Type 1 Diabetes , 2012, Diabetes.

[215]  Lawrence A Leiter,et al.  Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. , 2012, Archives of internal medicine.

[216]  N. Skolnik,et al.  Management of Hyperglycemia in Type 2 Diabetes , 2012 .

[217]  Jennifer Y. Liu,et al.  Symptom Burden of Adults with Type 2 Diabetes Across the Disease Course: Diabetes & Aging Study , 2012, Journal of General Internal Medicine.

[218]  Salim Yusuf,et al.  Basal insulin and cardiovascular and other outcomes in dysglycemia. , 2012, The New England journal of medicine.

[219]  C. Conner,et al.  Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes , 2012, Diabetes, obesity & metabolism.

[220]  E. Vittinghoff,et al.  Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial , 2012, Diabetes Care.

[221]  J. Wylie-Rosett,et al.  Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010 (Diabetes Care (2012) 35, (434-445)) , 2012 .

[222]  F. Rutten,et al.  High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes , 2012, Diabetologia.

[223]  P. Lips,et al.  Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. , 2012, Age and ageing.

[224]  C. Huang,et al.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies , 2012, Internal medicine journal.

[225]  A. Milne,et al.  Measuring Health-Related Quality of Life for Patients with Diabetic Retinopathy , 2012 .

[226]  Quan Dong Nguyen,et al.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. , 2012, Ophthalmology.

[227]  D. Sultzer,et al.  The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes , 2012, Journal of Behavioral Medicine.

[228]  P. Emery,et al.  Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. , 2012, Journal of the National Cancer Institute.

[229]  G. Umpierrez,et al.  Insulin therapy for the management of hyperglycemia in hospitalized patients. , 2012, Endocrinology and metabolism clinics of North America.

[230]  Michael E. Miller,et al.  Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes , 2012, Diabetes Care.

[231]  Paul Shekelle,et al.  Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians , 2012, Annals of Internal Medicine.

[232]  Adam Drewnowski,et al.  A conflict between nutritionally adequate diets and meeting the 2010 dietary guidelines for sodium. , 2012, American journal of preventive medicine.

[233]  G. Reboldi,et al.  Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes , 2012, Current Cardiology Reports.

[234]  K. Pesudovs,et al.  The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project , 2012, Quality of Life Research.

[235]  J. Wylie-Rosett,et al.  Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes , 2012, Diabetes Care.

[236]  A. Chang,et al.  Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis , 2012, Journal of the American Geriatrics Society.

[237]  B. Chaitman,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[238]  Stephanie J. Fonda,et al.  Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[239]  F. W. Germino Noninsulin treatment of type 2 diabetes mellitus in geriatric patients: a review. , 2011, Clinical therapeutics.

[240]  J. Zonszein,et al.  Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. , 2011, The American journal of medicine.

[241]  N. Bressler,et al.  Panretinal photocoagulation for proliferative diabetic retinopathy. , 2011, The New England journal of medicine.

[242]  A. Vinik,et al.  Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management , 2011, Diabetes/metabolism research and reviews.

[243]  Charles E. Leonard,et al.  Location, Location, Location: Geographic Clustering of Lower-Extremity Amputation Among Medicare Beneficiaries With Diabetes , 2011, Diabetes Care.

[244]  J. Birkmeyer,et al.  Racial disparities in the use of revascularization before leg amputation in Medicare patients. , 2011, Journal of vascular surgery.

[245]  B. Stuart,et al.  Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. , 2011, The American journal of geriatric pharmacotherapy.

[246]  Jennifer Y. Liu,et al.  Correlates of Quality of Life in Older Adults With Diabetes , 2011, Diabetes Care.

[247]  Xiaowu Sun,et al.  Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection , 2011, Diabetes Care.

[248]  P. Dodson,et al.  Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies , 2011, Eye.

[249]  Avan Aihie Sayer,et al.  A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. , 2011, Age and ageing.

[250]  V. Gudnason,et al.  Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study , 2011, BMJ Open.

[251]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[252]  S. Bangalore,et al.  Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials , 2011, Circulation.

[253]  T. Elgzyri,et al.  Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. , 2011, Journal of vascular surgery.

[254]  Jennifer Y. Liu,et al.  Glycemic Control, Complications, and Death in Older Diabetic Patients , 2011, Diabetes Care.

[255]  R. Hermida,et al.  Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes , 2011, Diabetes Care.

[256]  Å. Lernmark,et al.  Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus , 2011, Diabetes Care.

[257]  C. Cook,et al.  Update on inpatient glycemic control in hospitals in the United States. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[258]  J. Davidson,et al.  Mild renal impairment and the efficacy and safety of liraglutide. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[259]  G. Reboldi,et al.  Diuretic Treatment of Hypertension , 2011, Diabetes Care.

[260]  Francesco Bandello,et al.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.

[261]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[262]  Jennifer K. Sun,et al.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. , 2011, Ophthalmology.

[263]  Donald R. Miller,et al.  Trends in Initial Lower Extremity Amputation Rates Among Veterans Health Administration Health Care System Users From 2000 to 2004 , 2011, Diabetes Care.

[264]  N. Marchionni,et al.  Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials , 2011, Diabetes, obesity & metabolism.

[265]  G. Biessels,et al.  COGNITION IN OLDER PATIENTS WITH TYPE 1 DIABETES MELLITUS: A LONGITUDINAL STUDY , 2011, Journal of the American Geriatrics Society.

[266]  Medha N Munshi,et al.  Frequent hypoglycemia among elderly patients with poor glycemic control. , 2011, Archives of internal medicine.

[267]  Jerry L. Grenard,et al.  A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. , 2011, The American journal of geriatric pharmacotherapy.

[268]  Limin Peng,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.

[269]  M. Cesari Role of gait speed in the assessment of older patients. , 2011, JAMA.

[270]  M. Tinetti,et al.  Summary of the Updated American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons , 2011, Journal of the American Geriatrics Society.

[271]  Robert J. Anderson,et al.  Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial , 2010, Diabetes Care.

[272]  Mark Woodward,et al.  Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.

[273]  R. Freeman,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[274]  T. Aspray,et al.  Diabetes, falls and fractures. , 2010, Age and ageing.

[275]  Rodica Pop-Busui,et al.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.

[276]  R. Klein,et al.  Are Individuals With Diabetes Seeing Better? , 2010, Diabetes.

[277]  Walter T Ambrosius,et al.  Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.

[278]  G. Bakris,et al.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.

[279]  L. Ferrucci,et al.  Nutritional recommendations for the management of sarcopenia. , 2010, Journal of the American Medical Directors Association.

[280]  Lukasz Januszkiewicz [The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus]. , 2010, Kardiologia polska.

[281]  Mary Cushman,et al.  Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.

[282]  N. Wenger,et al.  Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients , 2010, Current gerontology and geriatrics research.

[283]  D. Mozaffarian,et al.  Diabetes and coronary heart disease as risk factors for mortality in older adults. , 2010, The American journal of medicine.

[284]  P. Wilson,et al.  Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.

[285]  J. Coresh,et al.  The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study , 2010, Diabetes.

[286]  W. Ambrosius,et al.  Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial , 2010, Diabetes Care.

[287]  John B Buse,et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.

[288]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[289]  G. Bakris,et al.  Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial , 2010, The Lancet.

[290]  R. DeFronzo Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 , 2010, Diabetologia.

[291]  K. Langa,et al.  Clinical Complexity in Middle-Aged and Older Adults With Diabetes: The Health and Retirement Study , 2010, Medical care.

[292]  H. Berlie,et al.  Diabetes Medications Related to an Increased Risk of Falls and Fall-Related Morbidity in the Elderly , 2010, The Annals of pharmacotherapy.

[293]  R. Heine,et al.  Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study , 2010, The Lancet.

[294]  C. MacGilchrist,et al.  Lower‐limb risk factors for falls in people with diabetes mellitus , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[295]  E. Margaret Warton,et al.  The Association Between the Number of Prescription Medications and Incident Falls in a Multi-ethnic Population of Adult Type-2 Diabetes Patients: The Diabetes and Aging Study , 2010, Journal of General Internal Medicine.

[296]  Sheri R. Colberg,et al.  Balance Training Reduces Falls Risk in Older Individuals With Type 2 Diabetes , 2010, Diabetes Care.

[297]  Michael E. Miller,et al.  The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.

[298]  D. Meier,et al.  Palliative Care in the Treatment of Advanced Heart Failure , 2009, Circulation.

[299]  M. Moser,et al.  Use of diuretics in patients with hypertension. , 2009, The New England journal of medicine.

[300]  K. Aminian,et al.  The gait and balance of patients with diabetes can be improved: a randomised controlled trial , 2009, Diabetologia.

[301]  David M Nathan,et al.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.

[302]  A. Schols,et al.  Muscle atrophy in cachexia: can dietary protein tip the balance? , 2009, Current opinion in clinical nutrition and metabolic care.

[303]  A. Farmer,et al.  Three-year efficacy of complex insulin regimens in type 2 diabetes. , 2009, The New England journal of medicine.

[304]  Todd A. Lee,et al.  Lower-Extremity Amputation Risk After Charcot Arthropathy and Diabetic Foot Ulcer , 2009, Diabetes Care.

[305]  David Kerr,et al.  Diabetes Interactive Diary: A New Telemedicine System Enabling Flexible Diet and Insulin Therapy While Improving Quality of Life , 2009, Diabetes Care.

[306]  K. Aminian,et al.  Clinical factors associated with gait alterations in diabetic patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[307]  D. Giugliano,et al.  Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes , 2009, Annals of Internal Medicine.

[308]  R. Heuberger Alcohol and the Older Adult: A Comprehensive Review , 2009, Journal of nutrition for the elderly.

[309]  M. Woodward,et al.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial , 2009, Diabetologia.

[310]  Paul P. Lee,et al.  Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression. , 2009, Ophthalmology.

[311]  G. Cherr,et al.  Superior limb salvage with endovascular therapy in octogenarians with critical limb ischemia. , 2009, Journal of vascular surgery.

[312]  Samy Suissa,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[313]  Mark V. Williams,et al.  Transitions of Care Consensus policy statement: American College of Physicians, Society of General Internal Medicine, Society of Hospital Medicine, American Geriatrics Society, American College Of Emergency Physicians, and Society for Academic Emergency Medicine. , 2009, Journal of hospital medicine.

[314]  E. Maltezos,et al.  Risk Factors for Ipsilateral Reamputation in Patients with Diabetic Foot Lesions , 2009, The international journal of lower extremity wounds.

[315]  M. Zhan,et al.  Frequency of hypoglycemia and its significance in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[316]  D. De Bacquer,et al.  Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. , 2009, Diabetes & metabolism.

[317]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[318]  R. Townsend,et al.  Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes. , 2009, Clinics in geriatric medicine.

[319]  H. Krumholz,et al.  Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.

[320]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[321]  J. Kushner,et al.  Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age , 2009, Diabetes.

[322]  A. Holstein,et al.  Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions , 2009, Expert opinion on drug metabolism & toxicology.

[323]  Nerrolyn Ramstrand,et al.  Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population , 2009, Diabetes Care.

[324]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[325]  G. Gensini,et al.  Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials , 2008, Diabetes, obesity & metabolism.

[326]  D. Belsky,et al.  Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. , 2008, Archives of ophthalmology.

[327]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.

[328]  U. Sambamoorthi,et al.  The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. , 2008, Journal of the American Medical Directors Association.

[329]  H. Parving,et al.  Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.

[330]  H. Parving,et al.  Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.

[331]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[332]  Y. Gustafson,et al.  Lower Systolic Blood Pressure Is Associated with Greater Mortality in People Aged 85 and Older , 2008, Journal of the American Geriatrics Society.

[333]  O. Johansen,et al.  Exenatide may aggravate moderate diabetic renal impairment: a case report. , 2008, British journal of clinical pharmacology.

[334]  A. Vinik,et al.  Diabetic neuropathy in older adults. , 2008, Clinics in geriatric medicine.

[335]  M. Chin,et al.  The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis , 2008, Annals of Internal Medicine.

[336]  D. Margolis,et al.  Association Between Renal Failure and Foot Ulcer or Lower-Extremity Amputation in Patients With Diabetes , 2008, Diabetes Care.

[337]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[338]  W. Paulus,et al.  Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study. , 2008, The Netherlands journal of medicine.

[339]  H. Woerle,et al.  Effect of Aging on Glucose Homeostasis , 2008, Diabetes Care.

[340]  Tamara B. Harris,et al.  Diabetes-related complications, glycemic control, and falls in older adults , 2008 .

[341]  Sally Kerry,et al.  Risk Factors for Fractures and Falls in Older Women with Type 2 Diabetes Mellitus , 2008, Calcified Tissue International.

[342]  I. Baumgartner,et al.  Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. , 2007, Journal of vascular surgery.

[343]  Paul Cook,et al.  The Relationship Between Glycemic Control and Falls in Older Adults , 2007, Journal of the American Geriatrics Society.

[344]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[345]  R. Nesto,et al.  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials , 2007, The Lancet.

[346]  Anushka Patel,et al.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.

[347]  K. Wolski,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[348]  J. McMurray,et al.  A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. , 2007, Journal of the American College of Cardiology.

[349]  P. Kothare,et al.  Effect of renal impairment on the pharmacokinetics of exenatide , 2007, British journal of clinical pharmacology.

[350]  D. Medeiros,et al.  Dietary Reference Intakes: the Essential Guide to Nutrient Requirements edited by JJ Otten, JP Hellwig, and LD Meyers, 2006, 560 pages, hardcover, $44.96. The National Academies Press, Washington, DC. , 2007 .

[351]  Richard W. Grant,et al.  Prevalence of Hyper- and Hypoglycemia Among Inpatients With Diabetes , 2007, Diabetes Care.

[352]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[353]  Luigi Ferrucci,et al.  Frailty: an emerging research and clinical paradigm--issues and controversies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[354]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[355]  G. Hitman,et al.  Analysis of Efficacy and Safety in Patients Aged 65–75 Years at Randomization , 2006, Diabetes Care.

[356]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[357]  James P. Boyle,et al.  Impact of Recent Increase in Incidence on Future Diabetes Burden , 2006, Diabetes Care.

[358]  Kathrin Maedler,et al.  Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. , 2006, Diabetes.

[359]  A. Chang,et al.  Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance , 2006 .

[360]  L. Goldstein,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006 .

[361]  W. Willett,et al.  Prospective Study of Diabetes and Risk of Hip Fracture , 2006, Diabetes Care.

[362]  J. Hsia,et al.  Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes , 2006, Diabetes Care.

[363]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[364]  Erland Erdmann,et al.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.

[365]  L. Lavery,et al.  Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. , 2005, Diabetes research and clinical practice.

[366]  E. Lewis,et al.  Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. , 2005, Journal of the American Society of Nephrology : JASN.

[367]  M. Maurer,et al.  Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[368]  J. Kushner,et al.  Very Slow Turnover of β-Cells in Aged Adult Mice , 2005 .

[369]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[370]  Ray Burke,et al.  A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. , 2005, Diabetes care.

[371]  H. Krumholz,et al.  Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure: An Observational Study , 2005, Circulation.

[372]  C. Bulpitt,et al.  Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. , 2005, Diabetes care.

[373]  P. Raskin,et al.  Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. , 2004, JAMA.

[374]  J. Mustonen,et al.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. , 2004, The New England journal of medicine.

[375]  Stephen J. Aldington,et al.  Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. , 2004, Archives of ophthalmology.

[376]  S. Kahn,et al.  Impact of Intra-Abdominal Fat and Age on Insulin Sensitivity and β-Cell Function , 2004 .

[377]  Robert A Berenson,et al.  Lost in Transition: Challenges and Opportunities for Improving the Quality of Transitional Care , 2004, Annals of Internal Medicine.

[378]  曲东锋 Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .

[379]  Y. Abe,et al.  Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. , 2004, Diabetes research and clinical practice.

[380]  Hylton B Menz,et al.  Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. , 2004, Archives of physical medicine and rehabilitation.

[381]  E. Rimon,et al.  Hypoglycemia as a predictor of mortality in hospitalized elderly patients. , 2003, Archives of internal medicine.

[382]  T. Inoue,et al.  Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure. , 2003, Clinical nephrology.

[383]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[384]  Claudio Cobelli,et al.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. , 2003, Diabetes.

[385]  C. Bulpitt,et al.  The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. , 2003, Diabetes care.

[386]  Quan Dong Nguyen,et al.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.

[387]  A. Monsch,et al.  Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women. , 2003, Age and ageing.

[388]  D. Eckland,et al.  The pharmacokinetics of pioglitazone in patients with impaired renal function. , 2003, British journal of clinical pharmacology.

[389]  Ann K. Miller,et al.  Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency , 2003, Journal of clinical pharmacology.

[390]  S. Studenski,et al.  Physical Performance Measures in the Clinical Setting , 2003, Journal of the American Geriatrics Society.

[391]  C. Hasslacher Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. , 2003, Diabetes care.

[392]  G. Gill,et al.  Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology , 2003 .

[393]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[394]  Pamela J Schreiner,et al.  Older women with diabetes have a higher risk of falls: a prospective study. , 2002, Diabetes care.

[395]  Peter Mansell Diabetes and driving , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[396]  Gary C. Brown,et al.  Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. , 2002, Archives of ophthalmology.

[397]  M. Franz,et al.  The evidence for the effectiveness of medical nutrition therapy in diabetes management. , 2002, Diabetes care.

[398]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[399]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[400]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[401]  A. Folsom,et al.  Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. , 2001, Diabetes care.

[402]  G. McVeigh,et al.  Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. , 2001, Clinical science.

[403]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[404]  C. Sueta,et al.  Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. , 2001, The American journal of cardiology.

[405]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[406]  R. Horswell,et al.  Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. , 2000, Diabetes care.

[407]  G. Bakris,et al.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[408]  F Prince,et al.  Evaluation of postural stability in elderly with diabetic neuropathy. , 2000, Diabetes care.

[409]  S. Grundy,et al.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.

[410]  L. Melton,et al.  Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. , 1999, Diabetes care.

[411]  D. Smith,et al.  Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. , 1999, Diabetes care.

[412]  D G Smith,et al.  A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. , 1999, Diabetes care.

[413]  B. Davis,et al.  Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.

[414]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[415]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[416]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[417]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[418]  Y. Friedlander,et al.  Hypoglycemia in Hospitalized Nondiabetic Older Patients , 1998, Journal of the American Geriatrics Society.

[419]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[420]  R. Schrier,et al.  Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[421]  A. Sjølie,et al.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.

[422]  H Lanshammar,et al.  Gait Abnormalities in Diabetic Neuropathy , 1997, Diabetes Care.

[423]  P. Thomas,et al.  Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.

[424]  W. Ray,et al.  Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, Archives of internal medicine.

[425]  A. Adler,et al.  Risk Factors for Diabetic Peripheral Sensory Neuropathy: Results of the Seattle Prospective Diabetic Foot Study , 1997, Diabetes Care.

[426]  Terje R Pedersen,et al.  Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.

[427]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[428]  D. Dills,et al.  Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[429]  Diana Dills1,et al.  Clinical Evaluation of Glimepiride versus Glyburide in NIDDM in a Double-Blind Comparative Study , 1996 .

[430]  W. Ray,et al.  Individual Sulfonylureas and Serious Hypoglycemia in Older People , 1996, Journal of the American Geriatrics Society.

[431]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[432]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[433]  A. Reuser,et al.  An evaluation of the potential side‐effects of α‐glucosidase inhibitors used for the management of diabetes mellitus , 1994, European journal of clinical investigation.

[434]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[435]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[436]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[437]  R. Lindeman Changes in Renal Function with Aging , 1992 .

[438]  J. Derr,et al.  Problems with Gait and Posture in Neuropathic Patients with Insulin‐Dependent Diabetes Mellitus , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[439]  W. Applegate,et al.  Instruments for the functional assessment of older patients. , 1990, The New England journal of medicine.

[440]  R. Kreisberg,et al.  Cholesterol metabolism and aging. , 1987, The American journal of medicine.

[441]  U S Nayak,et al.  Balance in elderly patients: the "get-up and go" test. , 1986, Archives of physical medicine and rehabilitation.

[442]  W. Duckworth,et al.  The renal metabolism of insulin , 1984, Diabetologia.

[443]  R E P O R T F R O M T H E A M E R I C A N D I A B E T E ,et al.  American Diabetes Association , 1978, Diabetes.

[444]  L. Balant,et al.  Pharmacokinetics of glipizide in man: Influence of renal insufficiency , 1973, Diabetologia.

[445]  C. Pieper,et al.  Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications , 2018, The Journal of clinical endocrinology and metabolism.

[446]  A. Sinclair,et al.  An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017 , 2017, The Journal of Frailty & Aging.

[447]  T. Bailey,et al.  Comparison of Insulin Glargine 300 U / mL and 100 U / mL in Adults With Type 1 Diabetes : Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections , 2017 .

[448]  M. Ruzicka,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2017, The New England journal of medicine.

[449]  N. Watts,et al.  Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. , 2016, The Journal of clinical endocrinology and metabolism.

[450]  P. Romano,et al.  Amputation Risk in Patients with Diabetes Mellitus and Peripheral Artery Disease Using Statewide Data. , 2016, Annals of vascular surgery.

[451]  N. Watts,et al.  Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin. , 2016, The Journal of clinical endocrinology and metabolism.

[452]  G. Biessels,et al.  Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. , 2015, The lancet. Diabetes & endocrinology.

[453]  Simeon I. Taylor,et al.  Possible adverse effects of SGLT2 inhibitors on bone. , 2015, The lancet. Diabetes & endocrinology.

[454]  D. Friedman,et al.  Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. , 2015, Ophthalmology.

[455]  C. Giorda,et al.  Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature , 2014, Endocrine.

[456]  M. Özkaya,et al.  Action to Control Cardiovascular Risk in Diabetes , 2013 .

[457]  P. P. Toth Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy , 2012 .

[458]  R. Klein,et al.  Diabetic retinopathy. , 2012, The New England journal of medicine.

[459]  Jackson T. Wright,et al.  Evidence-Based Guideline for the Management of High Blood Pressure in Adults , 2012 .

[460]  Michael S. Hong,et al.  Emerging national trends in the management and outcomes of lower extremity peripheral arterial disease. , 2011, Annals of Vascular Surgery.

[461]  Bijan Forogh,et al.  Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. , 2011, Journal of rehabilitation research and development.

[462]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[463]  B. Dorner,et al.  Practice paper of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. , 2010, Journal of the American Dietetic Association.

[464]  B. Dorner,et al.  Position of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. , 2010, Journal of the American Dietetic Association.

[465]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[466]  S. Schinner Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice , 2010 .

[467]  S. Schinner Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age , 2010 .

[468]  T. Dorman Intensive versus Conventional Glucose Control in Critically Ill Patients , 2010 .

[469]  40026386 Return Undeliverable,et al.  Canadian Agency for Drugs and Technologies in Health , 2009 .

[470]  H. Parving,et al.  DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. , 2008 .

[471]  J. E. Morley,et al.  The I.A.N.A. task force on frailty assessment of older people in clinical practice , 2008, The journal of nutrition, health & aging.

[472]  L. Kennedy,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .

[473]  Jennifer J. Otten,et al.  DRI, Dietary reference intakes : the essential guide to nutrient requirements , 2006 .

[474]  H. Ginsberg,et al.  Diabetic dyslipidemia. , 2006, Endocrinology and metabolism clinics of North America.

[475]  T. Elasy,et al.  Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association: response to Nesto. , 2004, Diabetes care.

[476]  A. Chang,et al.  Aging and insulin secretion. , 2003, American journal of physiology. Endocrinology and metabolism.

[477]  Lawrence A Leiter,et al.  Acarbose in the treatment of elderly patients with type 2 diabetes. , 2003, Diabetes research and clinical practice.

[478]  S. Grundy,et al.  Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. , 2003, Circulation.

[479]  Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1995, Ophthalmology.

[480]  H. Parving The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[481]  E. Lakatta Changes in cardiovascular function with aging. , 1990, European heart journal.